Andrews Nancy C

Andrews Nancy C, Director, has filed 2 insider trading reports covering 2 companies. Total disclosed trading volume is $681.5K. Purchases and sales are approximately balanced over this period. The largest single filing involves Maze Therapeutics, Inc. (MAZE). All transactions sourced from SEC Form 4 filings.